| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Kolling Institute of Medical Research (R.C.B.), St. Leonards, New South Wales 2065, Australia; INSERM U-142, Hopital Sainte-Antoine (M.A.B.), Paris, France; Department of Medicine, Division of Endocrinology, University of North Carolina School of Medicine (D.R.C.), Chapel Hill, North Carolina 27599-7170; Endocrine Research Unit, Mayo Clinic (C.A.C.), Rochester, Minnesota 55905-0001; Division of Endocrinology, Sophia Childrens Hospital (S.L.S.D.), Rotterdam, Netherlands; Department of Surgery, Bristol Royal Infirmary (J.M.P.H.) Bristol, United Kingdom; Department of Medicine, Loma Linda University (S.M.) Loma Linda, California 92357-0001; Department of Pediatrics, Oregon Health Sciences University (Y.O., R.G.R.) Portland, Oregon 97201
Address correspondence and requests for reprints to: Ron G. Rosenfeld, M.D., Department of Pediatrics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201. E-mail: rosenfer{at}ohsu.edu
| Introduction |
|---|
|
|
|---|
A closely related family of genes (CCN) has been identified, encoding immediate early gene products, connective tissue growth factor, and cyr61, as well as a putative avian proto-oncogene, nov (CCN stands for connective tissue growth factor, Cyr61/Cef10, nephroblastoma overexpressed gene) (9). The amino-terminal regions of the predicted proteins are structurally homologous to the classical IGFBPs, with conservation of the cysteine-rich region. As is the case with mac25/TAF/PSF/IGFBP-7, the carboxyl terminus of IGFBPs 16 is not conserved in these three proteins. The protein product of the CTGF gene has been synthesized in a baculovirus system and has been found to bind IGF-I and IGF-II with low affinity (10). This protein was provisionally named IGFBP-8, and, on the basis of their structural homologies, the protein products of nov and cyr61 were provisionally named IGFBP-9 and IGFBP-10, respectively (10).
The structural relationship of these proteins, especially in
the amino-terminal regions is clear and suggests that the classical six
IGFBPs and these low-affinity IGF binders are members of an IGFBP
superfamily. This superfamily consists of at least three gene families:
1) the IGFBPs, 2) the protein product of the mac25 gene, and 3) members
of the CCN family. In light of their relatively low affinities for IGF
peptides, it is recommended that they not be named IGF binding
proteins, but, rather, be termed insulin-like growth factor binding
protein-related proteins (IGFBP-rP), until further elucidation of their
molecular, biochemical, and physiological relationships to the
classical IGFBPs (see Table 1
).
|
Received March 20, 1998.
Revised May 7, 1998.
Accepted May 19, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. DeLellis, S. Rinaldi, R. J. Kaaks, L. N. Kolonel, B. Henderson, and L. Le Marchand Dietary and Lifestyle Correlates of Plasma Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3): The Multiethnic Cohort Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Grotendorst, L. F. Lau, and B. Perbal CCN Proteins Are Distinct from, and Should Not Be Considered Members of, the Insulin-Like Growth Factor-Binding Protein Superfamily J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 944 - 945. [Full Text] |
||||
![]() |
R. G. Rosenfeld, V. Hwa, and Y. Oh Nomenclature of the Insulin-Like Growth Factor-Binding Protein Superfamily J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 946 - 946. [Full Text] |
||||
![]() |
G. R. Devi, D.-H. Yang, R. G. Rosenfeld, and Y. Oh Differential Effects of Insulin-Like Growth Factor (IGF)-Binding Protein-3 and Its Proteolytic Fragments on Ligand Binding, Cell Surface Association, and IGF-I Receptor Signaling Endocrinology, November 1, 2000; 141(11): 4171 - 4179. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Baxter Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E967 - E976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Coverley, J. L. Martin, and R. C. Baxter The Effect of Phosphorylation by Casein Kinase 2 on the Activity of Insulin-Like Growth Factor-Binding Protein-3 Endocrinology, February 1, 2000; 141(2): 564 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Haugk, H.-M. P. Wilson, K. Swisshelm, and L. S. Quinn Insulin-Like Growth Factor (IGF)-Binding Protein-Related Protein-1: An Autocrine/Paracrine Factor That Inhibits Skeletal Myoblast Differentiation but Permits Proliferation in Response to IGF Endocrinology, January 1, 2000; 141(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text] |
||||
![]() |
R. G. Rosenfeld, V. Hwa, L. Wilson, A. Lopez-Bermejo, C. Buckway, C. Burren, W. K. Choi, G. Devi, A. Ingermann, D. Graham, et al. The Insulin-like Growth Factor Binding Protein Superfamily: New Perspectives Pediatrics, October 1, 1999; 104(4): 1018 - 1021. [Abstract] [Full Text] |
||||
![]() |
H. K. How, A. Yeoh, T. C. Quah, Y. Oh, R. G. Rosenfeld, and K.-O. Lee Insulin-Like Growth Factor Binding Proteins (IGFBPs) and IGFBP-Related Protein 1-Levels in Cerebrospinal Fluid of Children with Acute Lymphoblastic Leukemia J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1283 - 1287. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |